Sophia Genetics has added Hitachi to its list of shareholders following a $110m series F round that also included returning backer Swisscom.
Sophia Genetics, a Switzerland-based clinical insights platform, has raised $110m in its series F round from a consortium including Hitachi Ventures, the investment arm of conglomerate Hitachi.
Venture capital firm aMoon led the round, which took total funding to $250m. Other investors included Swisscom Ventures, the corporate venturing unit of the local telecoms operator, banks Credit Suisse and Pictet and investment firms Endeavour Vision, Generation Investment Management, Alychlo, Eurazeo Growth, ACE & Company and Famille C Invest.
This followed a series…
